DeepMed Research

LMC Diabetes & Endocrinology Ltd.

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Holding

Established: 1997-01-01

Employees: 51

Market Cap: -

Website: http://www.lmc.ca

Clinical Trials

The Current Health Status of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry

Completed

Conditions: Type1diabetes

First Posted Date: 2019-11-14

Last Posted Date: 2020-01-28

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 3600

Registration Number: NCT04162067

Locations: 🇨🇦
LMC Healthcare, Toronto, Canada

The Skills, Confidence & Preparedness Index (SCPI)

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Diabetes self-management education (DSME) program

First Posted Date: 2019-03-05

Last Posted Date: 2019-03-05

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 486

Registration Number: NCT03863561

Locations: 🇨🇦
LMC Barrie, Barrie, Ontario, Canada
🇨🇦
LMC Brampton, Brampton, Ontario, Canada
🇨🇦
LMC Etobicoke, Etobicoke, Ontario, Canada

and more 4 locations

Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered

Phase 4

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Insulin Degludec

First Posted Date: 2019-02-12

Last Posted Date: 2019-02-12

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 30

Registration Number: NCT03838783

Locations: 🇨🇦
LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Basal insulin glargine and lixisenatide
Drug: Basal insulin Basaglar/Lantus + gliclazide MR
Drug: Metformin

First Posted Date: 2019-01-29

Last Posted Date: 2021-02-25

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 119

Registration Number: NCT03819790

Locations: 🇨🇦
LMC Brampton, Brampton, Ontario, Canada
🇨🇦
LMC Etobicoke, Etobicoke, Ontario, Canada
🇨🇦
LMC Scarborough, Toronto, Ontario, Canada

Approaches To Therapy Escalation In T2D

Phase 4

Withdrawn

Conditions: Type2 Diabetes

Interventions: Drug: DPP-4 inhibitor
Drug: SGLT2 inhibitor
Drug: SGLT2 inhibitor and DPP-4 inhibitor

First Posted Date: 2019-01-23

Last Posted Date: 2019-09-27

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Registration Number: NCT03813316

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Completed

Conditions: NAFLD
Fatty Liver
T2DM (Type 2 Diabetes Mellitus)

Interventions: Other: Non-interventional

First Posted Date: 2017-07-28

Last Posted Date: 2017-07-28

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 4000

Registration Number: NCT03233178

Locations: 🇨🇦
LMC Brampton, Brampton, Ontario, Canada

Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)

Phase 4

Conditions: Diabetes Mellitus, Type 1

Interventions: Other: 0% bolus insulin correction
Drug: 50% bolus insulin correction
Drug: 100% bolus insulin correction
Drug: 150% bolus insulin correction

First Posted Date: 2017-02-20

Last Posted Date: 2017-02-20

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 18

Registration Number: NCT03057470

Locations: 🇨🇦
LMC Bayview, Toronto, Ontario, Canada

Randomized Trial Comparing Colesevelam vs. Ezetimibe

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Colesevelam
Drug: Ezetimibe

First Posted Date: 2016-02-15

Last Posted Date: 2019-11-26

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 200

Registration Number: NCT02682680

Locations: 🇨🇦
LMC Barrie, Barrie, Ontario, Canada
🇨🇦
LMC Brampton, Brampton, Ontario, Canada
🇨🇦
LMC Calgary, Calgary, Alberta, Canada

and more 6 locations

Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Other: Long-acting insulin glargine titration web tool (LTHome)
Other: Diabetes Education

First Posted Date: 2015-09-04

Last Posted Date: 2015-09-04

Lead Sponsor: LMC Diabetes & Endocrinology Ltd.

Target Recruit Count: 139

Registration Number: NCT02540486

Locations: 🇨🇦
LMC Diabetes & Endocrinology, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy